Atrial Support Pacing in Heart Failure: Results from the Multicenter PEGASUS CRT Trial
Authors:
- 25 July 2012
- journal article
- research article
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 23 (12) , 1317-1325
Abstract
Atrial Pacing in Heart Failure. Introduction: Cardiac resynchronization therapy (CRT) efficacy trials to date used atrial‐synchronous biventricular pacing wherein there is no or minimal atrial pacing. However, bradycardia and chronotropic incompetence are common in this patient population. This trial was designed to evaluate the effect of atrial support pacing among heart failure patients receiving a CRT defibrillator. Methods and Results: PEGASUS CRT was a multicenter, 3‐arm, randomized study. At 6 weeks, patients were randomized to DDD mode at a lower rate of 40 bpm (DDD‐40; control arm), or one of the following 2 treatment arms: DDD‐70, or DDDR‐40. The primary endpoint was a clinical composite endpoint that included all‐cause mortality, heart failure events, NYHA functional class, and patient global self‐assessment. Subjects were classified as improved, unchanged, or worsened at 12 months. There were 1,433 patients randomized, of whom 66% were male, mean age was 67 ± 11 years, and mean left ventricular ejection fraction was 23 ± 7%. The average follow‐up time was 10.5 ± 3.5 months and 1,309 patients contributed to the primary endpoint. No significant differences were observed in the composite endpoint between either of the 2 treatment arms compared to the control arm (P>0.05 for both comparisons). Additionally, there were no differences among the groups in mortality or heart failure events. Conclusion: In advanced heart failure patients treated with CRT, atrial support pacing did not improve clinical outcomes compared to atrial tracking. However, atrial pacing did not adversely affect mortality or heart failure events. (J Cardiovasc Electrophysiol, Vol. 23, pp. 1317‐1325, December 2012)Keywords
This publication has 35 references indexed in Scilit:
- Subclinical Atrial Fibrillation and the Risk of StrokeNew England Journal of Medicine, 2012
- Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart FailureNew England Journal of Medicine, 2010
- Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled studyThe Lancet, 2010
- SmartDelay Determined AV Optimization: A Comparison of AV Delay Methods Used in Cardiac Resynchronization Therapy (SMART-AV): Rationale and DesignPacing and Clinical Electrophysiology, 2009
- Heart Rate Predicts Outcomes in an Implantable Cardioverter-Defibrillator PopulationCirculation, 2009
- Acute Hemodynamic Effects of Atrial Pacing with Cardiac Resynchronization TherapyJournal of Cardiovascular Electrophysiology, 2009
- Impact of Cardiac Resynchronization Therapy on Exercise Performance, Functional Capacity, and Quality of Life in Systolic Heart Failure With QRS Prolongation: COMPANION Trial Sub-StudyJournal of Cardiac Failure, 2008
- Hemodynamic Effects of Atrial Septal Pacing in Cardiac Resynchronization Therapy PatientsJournal of Cardiovascular Electrophysiology, 2005
- A new pacemaker algorithm for the treatment of atrial fibrillationJACC, 2003
- Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: Reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendanAmerican Heart Journal, 1992